Lancaster-based startup CCI Photonics has secured substantial funding to enhance its rapid infection detection technology, which can provide results in 15 minutes. Their device, InfectiScan, leverages infrared spectrometry and AI to accurately identify bacterial infections and recommend effective antibiotics, addressing the growing issue of antibiotic resistance. Backed by various funding sources, including NPIF II and the Infection Innovation Consortium, the startup aims to revolutionize diagnostics, reducing reliance on inefficient traditional methods that can take up to 72 hours to deliver results. CCI Photonics emphasizes collaboration with healthcare partners to refine their unique technology.
With CCI Photonics' InfectiScan device, healthcare professionals will be able to rapidly identify pathogens and confirm antibiotic suitability, significantly improving patient outcomes.
This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges.
Collection
[
|
...
]